PHARMACOLOGY AND SIDE-EFFECTS OF INTERFERONS

被引：16
作者：
BOCCI, V
机构：
[1] Institute of General Physiology, the University of Siena
来源：
ANTIVIRAL RESEARCH | 1994年 / 24卷 / 2-3期
关键词：
INTERFERON; CATABOLIC PATHWAY; SIDE-EFFECTS;
D O I：
10.1016/0166-3542(94)90059-0
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The distribution, catabolic sites and turnover of interferons are reviewed in order firstly to improve their utilization, secondly to reduce toxicity and thirdly to evaluate alternative routes of administration. In fact catabolic pathways are now seen as a salutary system capable in most cases to reduce toxicity to an acceptable level.
引用
收藏
页码：111 / 119
页数：9
相关论文
共 44 条
[1]   INTERFERON-ALPHA THERAPY DURING PREGNANCY IN CHRONIC MYELOGENOUS LEUKEMIA AND HAIRY-CELL LEUKEMIA [J].
BAER, MR ;
OZER, H ;
FOON, KA .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 81 (02) :167-169
[2]  
BILLARD C, 1986, BLOOD, V67, P821
[3]  
BLATTEIS CM, 1990, YALE J BIOL MED, V63, P133
[4]   PHARMACOKINETICS OF HUMAN-LYMPHOBLASTOID INTERFERON IN RABBITS [J].
BOCCI, V ;
PESSINA, GP ;
PACINI, A ;
PAULESU, L ;
MUSCETTOLA, M ;
NALDINI, A ;
LUNGHETTI, G .
GENERAL PHARMACOLOGY, 1985, 16 (03) :277-279
[5]   THE LYMPHATIC ROUTE .5. DISTRIBUTION OF HUMAN NATURAL INTERFERON-BETA IN RABBIT PLASMA AND LYMPH [J].
BOCCI, V ;
PESSINA, GP ;
PAULESU, L ;
MUSCETTOLA, M ;
VALERI, A .
JOURNAL OF INTERFERON RESEARCH, 1988, 8 (05) :633-640
[6]  
BOCCI V, 1980, BIOMEDICINE, V32, P159
[7]   METABOLISM OF PROTEIN ANTICANCER AGENTS [J].
BOCCI, V .
PHARMACOLOGY & THERAPEUTICS, 1987, 34 (01) :1-49
[8]  
BOCCI V, 1992, CRIT REV THER DRUG, V9, P91
[9]   WHAT IS THE ROLE OF CARBOHYDRATES IN INTERFERONS [J].
BOCCI, V .
TRENDS IN BIOCHEMICAL SCIENCES, 1983, 8 (12) :432-434
[10]   ABSORPTION OF CYTOKINES VIA OROPHARYNGEAL-ASSOCIATED LYMPHOID-TISSUES - DOES AN UNORTHODOX ROUTE IMPROVE THE THERAPEUTIC INDEX OF INTERFERON [J].
BOCCI, V .
CLINICAL PHARMACOKINETICS, 1991, 21 (06) :411-417
12345